TY - JOUR
T1 - Rare disease education in Europe and beyond
T2 - time to act
AU - Tumiene, Birute
AU - Peters, Harm
AU - Melegh, Bela
AU - Peterlin, Borut
AU - Utkus, Algirdas
AU - Fatkulina, Natalja
AU - Pfliegler, György
AU - Graessner, Holm
AU - Hermanns, Sanja
AU - Scarpa, Maurizio
AU - Blay, Jean Yves
AU - Ashton, Sharon
AU - McKay, Lucy
AU - Baynam, Gareth
N1 - Funding Information:
ERN-RND, MetabERN and EURACAN are partly co-funded by the European Union within the framework of the Third Health Programme “ERN-2016—Framework Partnership Agreement 2017–2021.”
Funding Information:
This work was supported (not financially) by the European Reference Network for Rare Neurological Diseases, ERN-RND, European Reference Network for Inherited Metabolic Diseases, MetabERN, and European Reference Network for Rare Adult Solid Cancers, EURACAN.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - People living with rare diseases (PLWRD) still face huge unmet needs, in part due to the fact that care systems are not sufficiently aligned with their needs and healthcare workforce (HWF) along their care pathways lacks competencies to efficiently tackle rare disease-specific challenges. Level of rare disease knowledge and awareness among the current and future HWF is insufficient. In recent years, many educational resources on rare diseases have been developed, however, awareness of these resources is still limited and rare disease education is still not sufficiently taken into account by some crucial stakeholders as academia and professional organizations. Therefore, there is a need to fundamentally rethink rare disease education and HWF development across the whole spectrum from students to generalists, specialists and experts, to engage and empower PLWRD, their families and advocates, and to work towards a common coherent and complementary strategy on rare disease education and training in Europe and beyond. Special consideration should be also given to the role of nurse coordinators in care coordination, interprofessional training for integrated multidisciplinary care, patient and family-centered education, opportunities given by digital learning and fostering of social accountability to enforce the focus on socially-vulnerable groups such as PLWRD. The strategy has to be developed and implemented by multiple rare disease education and training providers: universities, medical and nursing schools and their associations, professional organizations, European Reference Networks, patient organizations, other organizations and institutions dedicated to rare diseases and rare cancers, authorities and policy bodies.
AB - People living with rare diseases (PLWRD) still face huge unmet needs, in part due to the fact that care systems are not sufficiently aligned with their needs and healthcare workforce (HWF) along their care pathways lacks competencies to efficiently tackle rare disease-specific challenges. Level of rare disease knowledge and awareness among the current and future HWF is insufficient. In recent years, many educational resources on rare diseases have been developed, however, awareness of these resources is still limited and rare disease education is still not sufficiently taken into account by some crucial stakeholders as academia and professional organizations. Therefore, there is a need to fundamentally rethink rare disease education and HWF development across the whole spectrum from students to generalists, specialists and experts, to engage and empower PLWRD, their families and advocates, and to work towards a common coherent and complementary strategy on rare disease education and training in Europe and beyond. Special consideration should be also given to the role of nurse coordinators in care coordination, interprofessional training for integrated multidisciplinary care, patient and family-centered education, opportunities given by digital learning and fostering of social accountability to enforce the focus on socially-vulnerable groups such as PLWRD. The strategy has to be developed and implemented by multiple rare disease education and training providers: universities, medical and nursing schools and their associations, professional organizations, European Reference Networks, patient organizations, other organizations and institutions dedicated to rare diseases and rare cancers, authorities and policy bodies.
KW - Highly-specialized knowledge
KW - Interprofessional learning
KW - Medical education and training
KW - Patient empowerment
KW - People living with rare disorders
KW - Rare disease awareness
KW - Social accountability
UR - http://www.scopus.com/inward/record.url?scp=85144302736&partnerID=8YFLogxK
U2 - 10.1186/s13023-022-02527-y
DO - 10.1186/s13023-022-02527-y
M3 - Article
C2 - 36536417
AN - SCOPUS:85144302736
VL - 17
JO - Orphanet Journal of Rare Diseases
JF - Orphanet Journal of Rare Diseases
SN - 1750-1172
IS - 1
M1 - 441
ER -